GSK tops list ranking big pharma's global access to medicine
Pharma companies move towards systematic access planning approaches: 2021 Access to Medicine Index - Express Pharma
Access to Medicines Index 2022: AstraZeneca on patent transparency
No profit, no pharma? – DW – 01/26/2021
Access to medicine index 2022 (ATMI)
Access to Medicine Index 2021 - The challenge for pharma companies: become a catalyst not a barrier
Access to Medicines Index 2022: AstraZeneca on patent transparency
Access to medicine index 2022 (ATMI)
Pharma companies making their products more accessible: Study - The Economic Times
List of countries included in the 2020 Access to Medicine Index -106... | Download Scientific Diagram
Pharmaceutical News - GSK, Pfizer, Sanofi driving medicines access
2021 Access to Medicine Index | Access to Medicine Foundation
2021 Q1 Results Presentation & Transcript | Novartis
GSK tops Access to Medicine Index (ATMI) for eighth consecutive time | GSK
Access to Medicine Index | Janssen EMEA
Access to Medicine Index 2021 - The challenge for pharma companies: become a catalyst not a barrier
Company profiles & report cards | Access to Medicine Foundation
Access to Medicine Index | Janssen EMEA
US pharma groups rise in 2010 Access to Medicine Index rankings
Pharma companies move towards systematic access planning approaches: 2021 Access to Medicine Index - Express Pharma
Access to medicine index 2022 (ATMI)
How Explanation Design uses Datylon to create a report with 250+ charts
Pharmaceutical industry doing more to improve access to medicine in developing countries
Seeking truer measures of success: Moving toward more rigorous evaluations of industry-led access to medicines programs
Pharma's path to 2030 captured in new framework for next Access to Medicine Index | Access to Medicine Foundation
Seeding Labs Recognized as Best Practice in Access to Medicine Index - Seeding Labs
